The Dallas Cowboys will have a former great announcing their selections on Friday night during the 2025 NFL draft.

This announcement was made alongside the reveal of positive Phase 3 results for Tanruprubart, a monoclonal antibody that can block C1q and can potentially halt neuroinflammation and nerve damage in ...

In a move that caps a storied career, eight-time Pro Bowl left tackle Tyron Smith has announced his retirement from the NFL, choosing to end his journey as a Dallas Cowboy. Smith, who has been a ...

Megyn Kelly, the American journalist, regrets her decision to get the Covid-19 vaccine, citing an autoimmune diagnosis ...

Annexon achieved primary endpoints in two Phase 3 studies for tanruprubart in treating Guillain-Barre Syndrome, setting the stage for a pre-BLA meeting ...

Good Friday Appeal executive director Rebecca Cowan said the initiative also aimed to give back to regional communities, which raised more than $5.2m last year. “The money they raise goes to the Royal ...

As millions of Brits battle runny noses, croaky coughs and watery eyes, it may be easy to chug an antihistamine, but the nation is also known for a series of common viruses this time of year.

The primary endpoint, outcome on the GBS Disability Score (GBS-DS) at 8 weeks, showed 29% of patients treated with ...

A former Beltrami County Jail nurse appeared in court Friday morning for a manslaughter charge stemming from the death of Hardel Sherrell.

We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at ...

To beef up its case for tanruprubart, Annexon also announced on Wednesday that a real-world study of the drug likewise showed a “rapid increase in muscle strength” versus current standards of care in ...

Annexon, Inc. (NASDAQ:ANNX) on Tuesday presented data for its late-stage targeted therapy, tanruprubart (formerly ANX005), ...